Uni Super Management Pty LTD Regeneron Pharmaceuticals, Inc. Transaction History
Uni Super Management Pty LTD
- $11.9 Billion
- Q2 2024
A detailed history of Uni Super Management Pty LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Uni Super Management Pty LTD holds 5,149 shares of REGN stock, worth $5.94 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
5,149
Previous 2,409
113.74%
Holding current value
$5.94 Million
Previous $2.32 Billion
99.77%
% of portfolio
0.05%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding REGN
# of Institutions
1,461Shares Held
84.5MCall Options Held
907KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$10.4 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$9.74 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$9.55 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$5.58 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$5.35 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $124B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...